TRRI — Alzex Neuropharma Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.15m
- $0.22m
Annual balance sheet for Alzex Neuropharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | |
---|---|---|
Period Length: | — | — |
Source: | PRESS | PRESS |
Standards: | — | — |
Status: | Final | Final |
Cash and Equivalents | ||
Cash and Short Term Investments | 0 | 0.001 |
Net Total Accounts Receivable | ||
Net Total Receivables | 0.002 | 0 |
Total Current Assets | 0.002 | 0.001 |
Net Property, Plant And Equipment | 0 | 0.032 |
Other Long Term Assets | ||
Total Assets | 0.084 | 0.033 |
Accounts Payable | ||
Accrued Expenses | ||
Total Other Current Liabilities | ||
Total Current Liabilities | 0.072 | 0.054 |
Long Term Debt | ||
Total Long Term Debt | ||
Total Debt | ||
Total Liabilities | 0.157 | 0.134 |
Common Stock | ||
Additional Paid In Capital | ||
Retained Earnings (Accumulated Deficit) | ||
Total Equity | -0.072 | -0.102 |
Total Liabilities & Shareholders' Equity | 0.084 | 0.033 |
Total Common Shares Outstanding |